chronic rhinosinusitis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: This was a retrospective study involving patients with CRSwNP hospitalized in the First Affiliated Hospital of Sun Yat-sen University (FAH-SYSU) and Ghent University from January 2018 to December 2020.The CRSwNP was diagnosed according to European Position Paper on Rhinosinusitis and Nasal Polyps 2020 (EPOS2020)7. Nasal polyp (NP) tissues from 70 patients at FAH were collected during surgery. None of the subjects had taken oral corticosteroids, immunomodulatory drugs within 4 weeks, nasal corticosteroids or oral antibiotics within 2 weeks before surgery.
Exclusion criteria
Exclusion criteria: Patients with fungal sinusitis, antrochoanal polyp, gastroesophageal reflux disease, immunodeficiency disease, primary ciliary immobility syndrome, cystic fibrosis, and parasitic diseases were excluded from the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| ROC curve; | — |
Secondary
| Measure | Time frame |
|---|---|
| Odds ratio; | — |
Countries
CHINA
Contacts
the first affiliated hospital of Sun Yat-sen University